[The effect of immunocorrective therapy on immunity in patients with idiopathic autoimmune cytopenias].
Tishchenko. L M LM
Key Findings
- Thymalin plus glucocorticoids improved immune parameters in patients with idiopathic autoimmune cytopenias
- The treatment corrected typical immune system disorders seen in this condition
- Authors recommend the regimen for clinical use
Practical Outcomes
- Thymalin may have immune‑boosting effects in autoimmune settings, but the evidence is limited to a tiny trial. Biohackers should view it as a preliminary hint rather than a ready‑to‑use protocol, and more research is needed before adopting it for general health or performance purposes.
Summary
A small study of 25 people with a rare autoimmune blood disorder found that adding the peptide thymalin to standard steroid treatment helped improve their immune system markers, and the researchers think this combo could be used in clinics.
Abstract
The author studied the effect of immunostimulating (thymalin) and immunodepressive agents (glucocorticoids) on the state of the immune system in 25 patients with idiopathic autoimmune cytopenias. It was established that the treatment favoured correction of disorders of the immune system characteristic of this kind of pathology. The proposed scheme is recommended for clinical employment in patients with idiopathic autoimmune cytopenias.
Study Information
pubmed
1991